Arbutus Biopharma (ABUS) Deferred Taxes (2014 - 2019)
Arbutus Biopharma (ABUS) posted Deferred Taxes of -$12.7 million for Q3 2019, down 195.68% sequentially from -$4.3 million in Q3 2018, and down 195.68% YoY from $13.2 million in Q3 2018.
Arbutus Biopharma (ABUS) Deferred Taxes (2014 - 2019) Analysis & Trends
Arbutus Biopharma has reported Deferred Taxes for 6 years, with the latest figure at -$12.7 million in Q3 2019.
- Quarterly Deferred Taxes fell 195.68% year-over-year to -$12.7 million in Q3 2019, while the trailing twelve-month figure through Dec 2020 was -$12.7 million (up 25.27% YoY) and the FY2019 annual result came in at -$12.7 million, down 195.68% from the prior year.
- Deferred Taxes declined to -$12.7 million in Q3 2019 per ABUS's latest filing, from -$4.3 million in the prior quarter.
- Over five years, Deferred Taxes peaked at $744000.0 in Q3 2017 and troughed at -$64.9 million in Q2 2016.
- A 5-year average of -$20.3 million and a median of -$13.9 million in 2015 frame the typical range for Deferred Taxes.
- The sharpest annual moves came in 2016 and 2017: Deferred Taxes sank 3964.41% in 2016, then jumped 37.65% in 2017.
- Over 5 years, Deferred Taxes stood at -$989000.0 in 2015, then tumbled by 3964.41% to -$40.2 million in 2016, then surged by 37.65% to -$25.1 million in 2017, then surged by 82.92% to -$4.3 million in 2018, then sank by 195.68% to -$12.7 million in 2019.
- According to Business Quant data, Deferred Taxes over the past three periods registered -$12.7 million, -$4.3 million, and -$25.1 million for Q3 2019, Q3 2018, and Q4 2017 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -137,876.64 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.66 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Arbutus Biopharma | 922.95 Mn | 830.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | -12.66 Mn |
| Sep 30, 2018 | -4.28 Mn |
| Dec 31, 2017 | -25.06 Mn |
| Sep 30, 2017 | 744,000.00 |
| Dec 31, 2016 | -40.20 Mn |
| Jun 30, 2016 | -64.86 Mn |
| Dec 31, 2015 | -989,000.00 |
| Sep 30, 2015 | -15.20 Mn |
| Jun 30, 2014 | 57,000.00 |